Journal of child neurology · 2008
Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD.
СтатьяРандомизированное исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gadow Kenneth D, Nolan Edith E, Sverd Jeffrey, Sprafkin Joyce, Schneider Jayne
Аннотация
Our primary objective was to determine if immediate-release methylphenidate is an effective treatment for oppositional defiant disorder diagnosed from mother's report in children with both chronic multiple tic disorder and attention-deficit hyperactivity disorder (ADHD). Children (n = 31) aged 6 to 12 years received placebo and 3 doses of methylphenidate twice daily for 2 weeks each under double-blind conditions and were assessed with ratings scales and laboratory measures. Results indicated significant improvement in both oppositional and ADHD behaviors with medication; however, the magnitude of treatment effect varied considerably as a function of disorder (ADHD > Oppositional behaviors), informant (teacher > mother), assessment instrument, and specific oppositional behavior (rebellious > disobeys rules). Drug response was comparable with that in children (n = 26) who did not have diagnosed oppositional defiant disorder, but comorbidity appeared to alter the perceived benefits for ADHD according to mother's report. Methylphenidate is an effective short-term treatment for oppositional behavior in children with comorbid ADHD and chronic multiple tic disorder.
Предметные рубрики MeSH
Age FactorsAggressionAttention Deficit Disorder with HyperactivityAttention Deficit and Disruptive Behavior DisordersCentral Nervous System StimulantsChildComorbidityDisability EvaluationDouble-Blind MethodDrug Administration ScheduleFemaleHumansMaleMethylphenidateNeuropsychological TestsPlacebosSex FactorsTic DisordersTreatment Outcome